Financial Strategies Group Inc. Buys 722 Shares of DaVita Inc. (NYSE:DVA)

Financial Strategies Group Inc. boosted its stake in shares of DaVita Inc. (NYSE:DVAFree Report) by 23.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 3,857 shares of the company’s stock after purchasing an additional 722 shares during the period. Financial Strategies Group Inc.’s holdings in DaVita were worth $592,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its stake in DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC boosted its stake in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new stake in DaVita during the 3rd quarter valued at $4,094,000. Assenagon Asset Management S.A. boosted its stake in DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after purchasing an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in DaVita during the 3rd quarter valued at $726,000. Institutional investors own 90.12% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DVA shares. Barclays raised their price target on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial raised their target price on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $161.80.

Get Our Latest Analysis on DVA

DaVita Stock Down 0.2 %

Shares of NYSE:DVA opened at $176.16 on Monday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The firm has a market capitalization of $14.44 billion, a PE ratio of 19.00, a price-to-earnings-growth ratio of 0.86 and a beta of 0.93. The business has a 50 day simple moving average of $159.72 and a two-hundred day simple moving average of $155.28. DaVita Inc. has a 1 year low of $107.74 and a 1 year high of $179.60.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.